Veterinary Medicines

PARACOX ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Eimeria acervulina, strain HP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria tenella, strain HP, Live
Download as PDF

Product identification

Medicine name:
PARACOX ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Eimeria acervulina, strain HP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria tenella, strain HP, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria acervulina, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria brunetti, strain HP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria maxima, strain MFP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria maxima, strain CP, Live
    200.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria mitis, strain HP, Live
    1000.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria necatrix, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria praecox, strain HP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria tenella, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 31896/93/18-01-1994/K-0085001
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."